Maravai (MRVI) Advances in RNA Research With New Collaboration

Maravai LifeSciences' (MRVI) business, TriLink BioTechnologies, recently partnered with Johns Hopkins University to significantly enhance research in RNA therapeutics. This collaboration aims to accelerate therapeutic development through a new center within the Johns Hopkins Whiting School of Engineering, leveraging TriLink's cutting-edge RNA synthesis technology. Financial terms of the deal were not revealed. Investment and Technological Contribution TriLink BioTechnologies works as a best-in-class contrac ...